BRPI0501132A - Process for obtaining pyrazolopyrimidinones, obtained pyrazolopyrimidinones, pharmaceutical composition containing said compound, pharmaceutical composition for preventive or curative treatment of erectile dysfunction, process for preparing pharmaceutical composition, use of said pharmaceutical composition, use of said compound or its salts - Google Patents
Process for obtaining pyrazolopyrimidinones, obtained pyrazolopyrimidinones, pharmaceutical composition containing said compound, pharmaceutical composition for preventive or curative treatment of erectile dysfunction, process for preparing pharmaceutical composition, use of said pharmaceutical composition, use of said compound or its saltsInfo
- Publication number
- BRPI0501132A BRPI0501132A BR0501132-9A BRPI0501132A BRPI0501132A BR PI0501132 A BRPI0501132 A BR PI0501132A BR PI0501132 A BRPI0501132 A BR PI0501132A BR PI0501132 A BRPI0501132 A BR PI0501132A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- pyrazolopyrimidinones
- compound
- preventive
- obtaining
- Prior art date
Links
Abstract
"PROCESSO DE OBTENçãO DE PIRAZOLOPIRIMIDINONAS, PIRAZOLOPIRIMIDINONAS OBTIDAS, COMPOSIçãO FARMACêUTICA CONTENDO DITO COMPOSTO, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO PREVENTIVO OU CURATIVO DE DISFUNçãO ERéTIL, PROCESSO PARA PREPARAR COMPOSIçãO FARMACêUTICA, USO DA DITA COMPOSIçãO FARMACêUTICA, USO DO DITO COMPOSTO OU SEUS SAIS". A invenção reporta-se a um novo processo de obtenção de pirazolopirimidinonas particularmente úteis no tratamento preventivo ou curativo da disfunção erétil masculina. A invenção compreende também as pirazolopírimidinonas obtidas pelo citado processo, a composição farmacêutica compreendendo citados compostos, bem como o uso dos ditos compostos e composições farmacêuticas comportando-os na preparação de medicamento para tratar preventiva ou curativamente a disfunção erétil."PROCEDURE FOR OBTAINING PIRAZOLOPYRIMIDINES, PIRAZOLOPYRIMIDINES OBTAINED, PHARMACEUTICAL COMPOSITION CONTAINING COMPOUND, PHARMACEUTICAL COMPOSITION FOR PREVENTIVE OR CUREDAL PROFESSIONAL SAFETY PROCESSING The invention relates to a novel process for obtaining pyrazolopyrimidinones particularly useful in the preventive or curative treatment of male erectile dysfunction. The invention also comprises the pyrazolopyrimidinones obtained by said process, the pharmaceutical composition comprising said compounds, as well as the use of said compounds and pharmaceutical compositions comprising them in the preparation of medicament to preventively or curatively treat erectile dysfunction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0501132-9A BRPI0501132A (en) | 2005-03-31 | 2005-03-31 | Process for obtaining pyrazolopyrimidinones, obtained pyrazolopyrimidinones, pharmaceutical composition containing said compound, pharmaceutical composition for preventive or curative treatment of erectile dysfunction, process for preparing pharmaceutical composition, use of said pharmaceutical composition, use of said compound or its salts |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0501132-9A BRPI0501132A (en) | 2005-03-31 | 2005-03-31 | Process for obtaining pyrazolopyrimidinones, obtained pyrazolopyrimidinones, pharmaceutical composition containing said compound, pharmaceutical composition for preventive or curative treatment of erectile dysfunction, process for preparing pharmaceutical composition, use of said pharmaceutical composition, use of said compound or its salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0501132A true BRPI0501132A (en) | 2006-01-24 |
Family
ID=35610311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0501132-9A BRPI0501132A (en) | 2005-03-31 | 2005-03-31 | Process for obtaining pyrazolopyrimidinones, obtained pyrazolopyrimidinones, pharmaceutical composition containing said compound, pharmaceutical composition for preventive or curative treatment of erectile dysfunction, process for preparing pharmaceutical composition, use of said pharmaceutical composition, use of said compound or its salts |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0501132A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166157A (en) * | 2018-11-28 | 2021-07-23 | 托帕杜制药公司 | Novel double-acting mode soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
-
2005
- 2005-03-31 BR BR0501132-9A patent/BRPI0501132A/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166157A (en) * | 2018-11-28 | 2021-07-23 | 托帕杜制药公司 | Novel double-acting mode soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0508540A8 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
| BRPI0514691A (en) | compound or a pharmaceutically acceptable salt thereof, process for preparing it, pharmaceutical composition, and use of a compound or pharmaceutically acceptable salt thereof | |
| BRPI0518126A (en) | compound, process for preparing same, pharmaceutical composition, use of a compound, and methods for producing a b-raf inhibitory effect and an anti-cancer effect on a warm-blooded animal, and for treating a disease or condition | |
| BRPI0512075A (en) | compound, process for the preparation thereof, pharmaceutical composition, use of a compound, and methods for producing a b-raf inhibiting effect, and an anticancer effect on a warm-blooded animal, and for treating a disease | |
| BRPI0512796A (en) | compound, process for preparing same, pharmaceutical composition, use of a compound, and methods for producing an inhibitory effect of b-raf, and an anticancer effect on a warm-blooded animal, and for treating a disease. | |
| BRPI0519280A2 (en) | compound, pharmaceutical composition and use of a compound | |
| BRPI0606793A8 (en) | compound or a pharmaceutically acceptable salt thereof, process for the preparation and use thereof, methods for inhibiting trk activity, treating or prophylaxis cancer, and producing an antiproliferative effect in a warm-blooded animal and pharmaceutical composition | |
| BRPI0606930A2 (en) | compound or a pharmaceutically acceptable salt thereof, process for preparing a compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and methods for producing a drug inhibiting effect. b-raf in a warm-blooded animal, for producing an anti-cancer effect on a warm-blooded animal and for treating diseases of an animal in a warm-blooded animal | |
| BRPI0818533B8 (en) | compound, pharmaceutical composition, use of a compound, and, process for preparing a compound | |
| BRPI0410477A (en) | compound or a pharmaceutically acceptable salt thereof, method for the prophylaxis or treatment of a chiral condition in a mammal, pharmaceutical formulation, combination, use of a compound, and process for preparing a compound | |
| BRPI0513085A (en) | Bicyclically substituted 8-pyrrolidinoxanthines, and their use as dipeptidyl peptidase inhibitors | |
| BRPI0607796A2 (en) | compound or a pharmaceutically acceptable salt thereof, process for preparation and use thereof, and pharmaceutical composition | |
| BRPI0514679A (en) | compound, process for preparing same, pharmaceutical composition, use of a compound, and methods for producing an inhibitory effect of b-raf and an anticancer effect on a warm-blooded animal, and for treating a disease or condition | |
| BR112013032974A2 (en) | "1,6-diazabicyclo [3,2,1] -octan-7-one derivatives, their uses, and pharmaceutical compositions". | |
| BR112014008045A2 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases | |
| CR20110270A (en) | Pyryloxy-indoles VEGF-R2 Inhibitors and Use of the Same for the Treatment of Diseases | |
| EA200901133A1 (en) | DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE | |
| BRPI0910439B8 (en) | thienopyridone derivatives as amp-activated protein kinase (ampk) activators, their preparation process, and medicines | |
| BRPI0519013A2 (en) | single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound | |
| BRPI0514091A (en) | Substituted 8-aminoalkylthioxanthines, and their use as dipepetidyl peptidase iv inhibitors | |
| BR0213522A (en) | A compound, pharmaceutical composition, methods of inhibiting HIV integrase and for preventing or treating HIV infection or for preventing, treating or delaying the onset of AIDS in a patient, and useful combination for treating or preventing HIV infection or for preventing , treat or delay the onset of AIDS | |
| CL2007001166A1 (en) | Compounds derived from condensed pyrimidine, pi3-kinase inhibitors; processes to prepare the compounds; pharmaceutical composition that includes them; use of the compounds in the preparation of medicaments; process to prepare the pharmaceutical composition; and kit that includes the pharmaceutical composition | |
| BRPI0513717A (en) | pyridine derivatives | |
| DOP2006000084A (en) | SULFOXIMINO-MACROCICLIC COMPOUNDS AND THEIR SALTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PREPARATION METHODS AND USES OF THE SAME | |
| BR112014006297A2 (en) | cathepsin c n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors, their uses, and pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: BASEADO NO ARTIGO 216 1O DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO, NESTA DEVE CONSTAR ONOME DE TODOS OS DEPOSITANTES, PARA QUE ENTAO SEJA ACEITA. |
|
| B03B | Publication of an application: publication anticipated [chapter 3.2 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A,4A E 5A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2086 DE 28/12/2010. |